\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ was\\ non\\-contributory\\.\ \(0\)\
\-\ ct\\:\\ \\ \\ single\\ transverse\\ section\\ through\\ the\\ liver\\ with\\ iv\\ contrast\\.\\ \\ multiple\\ smooth\\-contoured\\ hepatic\\ lesions\\ of\\ higher\\ attenuation\\ than\\ the\\ surrounding\\ hepatic\\ parenchyma\\ are\\ noted\\ in\\ the\\ left\\ lobe\\.\\ \\ one\\ extremely\\ large\\ lesion\\,\\ which\\ abuts\\ the\\ hepatic\\ capsule\\,\\ is\\ of\\ particular\\ note\\ because\\ of\\ its\\ size\\.\\ \\ there\\ is\\ no\\ evidence\\ of\\ intra\\-lesion\\ scarring\\ or\\ calcification\\ noted\\.\ \(0\)\
\-\ us\\:\\ \\ single\\ longitudinal\\ image\\ of\\ liver\\ showing\\ hypoechoic\\ regions\\ with\\ smooth\\ margins\\ consistent\\ with\\ findings\\ on\\ ct\\.\\ \\ single\\ doppler\\ enhanced\\ transverse\\ image\\ of\\ same\\ hepatic\\ region\\ showing\\ blood\\ flow\\ to\\ the\\ largest\\ hypoechoic\\ region\\ of\\ liver\\.\\ \\ these\\ findings\\ suggests\\ vascularization\\ of\\ a\\ large\\ hepatic\\ mass\\ with\\ multiple\\ non\\-vascularized\\ smaller\\ satellite\\ masses\\.\ \(0\)\
\-\ hepatocellular\\ carcinoma\\ confirmed\\ on\\ us\\-guided\\ needle\\ biopsy\\.\ \(0\)\
\-\ \\<li\\>hepatocellular\\ carcinoma\ \(0\)\
\-\ \\<li\\>focal\\ nodular\\ hyperplasia\ \(0\)\
\-\ \\<li\\>hepatic\\ adenoma\ \(0\)\
\-\ \\<li\\>hemangioma\\ \ \(0\)\
\-\ \\<li\\>focal\\ fat\ \(0\)\
\-\ \\<li\\>focal\\ confluent\\ fibrosis\ \(0\)\
\-\ \\<li\\>primary\\ hepatic\\ lymphoma\ \(0\)\
\-\ \\<li\\>fibrolamellar\\ carcinoma\ \(0\)\
\-\ \\<li\\>angiosarcoma\ \(0\)\
\-\ \\<li\\>metastasis\ \(3\)\
\-\ h\\/o\\ hepatitis\\ c\\.\ \(0\)\
\-\ when\\ a\\ mass\\-like\\ lesion\\ in\\ the\\ liver\\ is\\ observed\\ on\\ imaging\\,\\ the\\ next\\ step\\ is\\ to\\ attempt\\ determining\\ which\\ diagnosis\\ best\\ fits\\ the\\ given\\ radiologic\\ findings\\.\\ given\\ the\\ findings\\ noted\\ above\\,\\ focal\\ confluent\\ fibrosis\\ \\(fcf\\)\\,\\ focal\\ fat\\,\\ and\\ hemangioma\\ can\\ be\\ removed\\ from\\ the\\ differential\\.\\ \\ fcf\\ tends\\ to\\ be\\ of\\ equal\\ or\\ slightly\\ lower\\ attenuation\\ as\\ surrounding\\ normal\\ parenchyma\\ on\\ iv\\ contrast\\-enhanced\\ ct\\.\\ \\ focal\\ fat\\ will\\ be\\ of\\ low\\ attenuation\\ similar\\ to\\ subcutaneous\\ fat\\ on\\ ct\\.\\ \\ the\\ benign\\ lesion\\,\\ hemangioma\\,\\ will\\ attenuate\\ similar\\ to\\ blood\\ and\\ will\\ display\\ increased\\ attentuation\\ on\\ enhancement\\.\\ \\ however\\,\\ when\\ contrast\\ is\\ added\\ to\\ enhance\\,\\ the\\ hemangioma\\ will\\ exhibit\\ delayed\\ enhancement\\ in\\ a\\ centripetal\\ pattern\\,\\ unlike\\ the\\ \\‚\\Ä\\úinstant\\‚\\Ä\\ù\\ and\\ complete\\ enhancement\\ of\\ the\\ lesions\\ shown\\ above\\.\\ \\ enhancement\\ is\\ delayed\\ secondary\\ to\\ the\\ relatively\\ low\\ flow\\ state\\ within\\ the\\ lesion\\.\\ \\ primary\\ hepatic\\ lymphoma\\ usually\\ appears\\ multilobulated\\ and\\ poorly\\ enhancing\\ on\\ ct\\.\\ \\ fibrolamellar\\ carcinomas\\ are\\ hyperechoic\\ lesions\\ on\\ us\\ and\\ often\\ display\\ punctate\\ calcifications\\ and\\ low\\ attenuation\\ on\\ enhanced\\ ct\\.\\ \\ metastases\\ will\\ most\\ commonly\\ show\\ scattered\\ small\\ lesions\\ throughout\\ the\\ hepatic\\ parenchyma\\ rather\\ than\\ the\\ large\\ lesion\\ depicted\\ in\\ the\\ attached\\ ct\\ and\\ us\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ li\\:\\ 0\\.43936900754598734\ \(0\)\
\-\ hepatic\\:\\ 0\\.3321009238487979\ \(0\)\
\-\ the\\:\\ 0\\.1756706626806357\ \(0\)\
\-\ focal\\:\\ 0\\.16629864456857513\ \(0\)\
\-\ hemangioma\\:\\ 0\\.15590925950148207\ \(0\)\
\-\ will\\:\\ 0\\.1491172750213557\ \(0\)\
\-\ fcf\\:\\ 0\\.14820452019209573\ \(0\)\
\-\ us\\:\\ 0\\.14743421067453177\ \(0\)\
\-\ attenuation\\:\\ 0\\.14181556824496722\ \(0\)\
\-\ lesion\\:\\ 0\\.13328868956726334\ \(0\)\
\-\ liver\\:\\ 0\\.1278604256647899\ \(0\)\
\-\ on\\:\\ 0\\.12594995063243378\ \(0\)\
\-\ ct\\:\\ 0\\.12348536598399706\ \(0\)\
\-\ fat\\:\\ 0\\.11529681763656963\ \(0\)\
\-\ fibrolamellar\\:\\ 0\\.11442189785027174\ \(0\)\
\-\ parenchyma\\:\\ 0\\.1129231518458126\ \(0\)\
\-\ display\\:\\ 0\\.11000406073965421\ \(0\)\
\-\ confluent\\:\\ 0\\.10717151434973665\ \(0\)\
\-\ single\\:\\ 0\\.10689030886226968\ \(0\)\
\-\ enhancement\\:\\ 0\\.10668208819761357\ \(0\)\
\-\ lesions\\:\\ 0\\.10644646704556499\ \(0\)\
\-\ enhanced\\:\\ 0\\.10584426798137767\ \(0\)\
\-\ of\\:\\ 0\\.09974647437380983\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.09527346024593902\ \(0\)\
\-\ findings\\:\\ 0\\.09147581996035538\ \(0\)\
\-\ carcinoma\\:\\ 0\\.08314932228428756\ \(0\)\
\-\ to\\:\\ 0\\.08108835726547049\ \(0\)\
\-\ showing\\:\\ 0\\.08001674696155676\ \(0\)\
\-\ low\\:\\ 0\\.07976452119968729\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.07918343572955994\ \(0\)\
\-\ fibrosis\\:\\ 0\\.07763502585838858\ \(0\)\
\-\ smooth\\:\\ 0\\.07651416716868538\ \(0\)\
\-\ is\\:\\ 0\\.07613750412043888\ \(0\)\
\-\ noted\\:\\ 0\\.0737027418785873\ \(0\)\
\-\ delayed\\:\\ 0\\.07251906832075092\ \(0\)\
\-\ transverse\\:\\ 0\\.0714033434617873\ \(0\)\
\-\ instant\\:\\ 0\\.07080866555504924\ \(0\)\
\-\ similar\\:\\ 0\\.07063124966298923\ \(0\)\
\-\ large\\:\\ 0\\.06965076246704058\ \(0\)\
\-\ attenuate\\:\\ 0\\.0684718230390772\ \(0\)\
\-\ attentuation\\:\\ 0\\.0684718230390772\ \(0\)\
\-\ contrast\\:\\ 0\\.06754197728444489\ \(0\)\
\-\ and\\:\\ 0\\.06702419169381688\ \(0\)\
\-\ above\\:\\ 0\\.06685594674004945\ \(0\)\
\-\ vascularization\\:\\ 0\\.06665922716394343\ \(0\)\
\-\ iv\\:\\ 0\\.06621667709719135\ \(0\)\
\-\ centripetal\\:\\ 0\\.0639260619677964\ \(0\)\
\-\ given\\:\\ 0\\.0637496997836911\ \(0\)\
\-\ satellite\\:\\ 0\\.06284138598210653\ \(0\)\
\-\ surrounding\\:\\ 0\\.06180630426754146\ \(0\)\
\-\ flow\\:\\ 0\\.06172686153104726\ \(0\)\
\-\ depicted\\:\\ 0\\.06102879010697276\ \(0\)\
\-\ fits\\:\\ 0\\.05954779144110791\ \(0\)\
\-\ image\\:\\ 0\\.059267876740654105\ \(0\)\
\-\ multilobulated\\:\\ 0\\.05829562491082574\ \(0\)\
\-\ primary\\:\\ 0\\.05698398135301266\ \(0\)\
\-\ abuts\\:\\ 0\\.05671849490265202\ \(0\)\
\-\ be\\:\\ 0\\.056390679884240694\ \(0\)\
\-\ added\\:\\ 0\\.05625419690010928\ \(0\)\
\-\ when\\:\\ 0\\.055979936819282775\ \(0\)\
\-\ region\\:\\ 0\\.05543288152285838\ \(0\)\
\-\ step\\:\\ 0\\.0553983530500021\ \(0\)\
\-\ lymphoma\\:\\ 0\\.05519259108619893\ \(0\)\
\-\ angiosarcoma\\:\\ 0\\.05500203036982711\ \(0\)\
\-\ blood\\:\\ 0\\.05382102013821382\ \(0\)\
\-\ determining\\:\\ 0\\.053585757174868326\ \(0\)\
\-\ tends\\:\\ 0\\.053585757174868326\ \(0\)\
\-\ exhibit\\:\\ 0\\.053585757174868326\ \(0\)\
\-\ than\\:\\ 0\\.052533766244023665\ \(0\)\
\-\ carcinomas\\:\\ 0\\.05183840665950893\ \(0\)\
\-\ unlike\\:\\ 0\\.0515805118681652\ \(0\)\
\-\ attached\\:\\ 0\\.04918045499721\ \(0\)\
\-\ punctate\\:\\ 0\\.04828691732716658\ \(0\)\
\-\ scarring\\:\\ 0\\.047794463304682726\ \(0\)\
\-\ attempt\\:\\ 0\\.047794463304682726\ \(0\)\
\-\ hepatitis\\:\\ 0\\.04763673012296951\ \(0\)\
\-\ extremely\\:\\ 0\\.047482001566265634\ \(0\)\
\-\ largest\\:\\ 0\\.04718111518231198\ \(0\)\
\-\ state\\:\\ 0\\.04674970387902235\ \(0\)\
\-\ in\\:\\ 0\\.04610813745082835\ \(0\)\
\-\ capsule\\:\\ 0\\.045339034688163124\ \(0\)\
\-\ multiple\\:\\ 0\\.04532844797970927\ \(0\)\
\-\ particular\\:\\ 0\\.045222154921750635\ \(0\)\
\-\ equal\\:\\ 0\\.04434313558197089\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.044137478936060764\ \(0\)\
\-\ longitudinal\\:\\ 0\\.04403657076114136\ \(0\)\
\-\ next\\:\\ 0\\.04327148767224154\ \(0\)\
\-\ radiologic\\:\\ 0\\.04318072691103418\ \(0\)\
\-\ needle\\:\\ 0\\.04300219217219109\ \(0\)\
\-\ suggests\\:\\ 0\\.04274153867692541\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.04265648027019592\ \(0\)\
\-\ section\\:\\ 0\\.042244056487385225\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.042244056487385225\ \(0\)\
\-\ which\\:\\ 0\\.04213939720044589\ \(0\)\
\-\ higher\\:\\ 0\\.042084776803312254\ \(0\)\
\-\ poorly\\:\\ 0\\.04185156450929497\ \(0\)\
\-\ smaller\\:\\ 0\\.04169972824516932\ \(0\)\
\-\ doppler\\:\\ 0\\.041477166278651445\ \(0\)\
\-\ enhance\\:\\ 0\\.041477166278651445\ \(0\)\
\-\ observed\\:\\ 0\\.041260540011060554\ \(0\)\
\-\ rather\\:\\ 0\\.041049541040972255\ \(0\)\
\-\ scattered\\:\\ 0\\.040319637754223876\ \(0\)\
\-\ regions\\:\\ 0\\.039767674281550904\ \(0\)\
\-\ margins\\:\\ 0\\.03953390264832734\ \(0\)\
\-\ removed\\:\\ 0\\.039362885729197286\ \(0\)\
\-\ pe\\:\\ 0\\.03830646369762807\ \(0\)\
\-\ relatively\\:\\ 0\\.03773283694350442\ \(0\)\
\-\ metastases\\:\\ 0\\.03746053199471805\ \(0\)\
\-\ best\\:\\ 0\\.037283938004568966\ \(0\)\
\-\ adenoma\\:\\ 0\\.03694186625662088\ \(0\)\
\-\ nodular\\:\\ 0\\.03690010264986644\ \(0\)\
\-\ same\\:\\ 0\\.036653932186206606\ \(0\)\
\-\ with\\:\\ 0\\.03629311740671997\ \(0\)\
\-\ slightly\\:\\ 0\\.0361448545574705\ \(0\)\
\-\ shown\\:\\ 0\\.03592024106837065\ \(0\)\
\-\ mass\\:\\ 0\\.035398664195349365\ \(0\)\
\-\ are\\:\\ 0\\.0351652405354865\ \(0\)\
\-\ note\\:\\ 0\\.034881850128822556\ \(0\)\
\-\ pattern\\:\\ 0\\.03459456269139861\ \(0\)\
\-\ its\\:\\ 0\\.034286836362935724\ \(0\)\
\-\ commonly\\:\\ 0\\.034286836362935724\ \(0\)\
\-\ confirmed\\:\\ 0\\.034166937453719425\ \(0\)\
\-\ throughout\\:\\ 0\\.03407816057422179\ \(0\)\
\-\ metastasis\\:\\ 0\\.0339612808078093\ \(0\)\
\-\ appears\\:\\ 0\\.0339323217624491\ \(0\)\
\-\ calcifications\\:\\ 0\\.033817507078956116\ \(0\)\
\-\ calcification\\:\\ 0\\.033082261468029554\ \(0\)\
\-\ biopsy\\:\\ 0\\.03248028214194445\ \(0\)\
\-\ complete\\:\\ 0\\.03248028214194445\ \(0\)\
\-\ because\\:\\ 0\\.03238415079963558\ \(0\)\
\-\ or\\:\\ 0\\.03223933399952047\ \(0\)\
\-\ benign\\:\\ 0\\.03183009493774738\ \(0\)\
\-\ masses\\:\\ 0\\.031545048019885336\ \(0\)\
\-\ size\\:\\ 0\\.03137447999708985\ \(0\)\
\-\ often\\:\\ 0\\.03023460785143308\ \(0\)\
\-\ differential\\:\\ 0\\.03010725692195907\ \(0\)\
\-\ show\\:\\ 0\\.029415519736528506\ \(0\)\
\-\ usually\\:\\ 0\\.02917058649831012\ \(0\)\
\-\ enhancing\\:\\ 0\\.029027094970072578\ \(0\)\
\-\ through\\:\\ 0\\.02758305511046929\ \(0\)\
\-\ secondary\\:\\ 0\\.02746485248701941\ \(0\)\
\-\ however\\:\\ 0\\.027425830777293228\ \(0\)\
\-\ lobe\\:\\ 0\\.026777640132924357\ \(0\)\
\-\ one\\:\\ 0\\.02652986046327251\ \(0\)\
\-\ evidence\\:\\ 0\\.026300705531543622\ \(0\)\
\-\ these\\:\\ 0\\.026166252746843487\ \(0\)\
\-\ consistent\\:\\ 0\\.025124750992620456\ \(0\)\
\-\ increased\\:\\ 0\\.025056612755648553\ \(0\)\
\-\ imaging\\:\\ 0\\.024351434739670105\ \(0\)\
\-\ can\\:\\ 0\\.024315963051773474\ \(0\)\
\-\ most\\:\\ 0\\.024114953243348874\ \(0\)\
\-\ diagnosis\\:\\ 0\\.024020548546517893\ \(0\)\
\-\ small\\:\\ 0\\.02390196244597033\ \(0\)\
\-\ lower\\:\\ 0\\.0236780369874442\ \(0\)\
\-\ within\\:\\ 0\\.02134119447147216\ \(0\)\
\-\ normal\\:\\ 0\\.018918910107876497\ \(0\)\
\-\ as\\:\\ 0\\.018615043959370844\ \(0\)\
\-\ there\\:\\ 0\\.018437176693547854\ \(0\)\
\-\ from\\:\\ 0\\.018402920433520896\ \(0\)\
\-\ was\\:\\ 0\\.016148752780818933\ \(0\)\
\-\ left\\:\\ 0\\.015806414023133\ \(0\)\
\-\ no\\:\\ 0\\.015068124736419858\ \(0\)\
